A woman has been sober from alcohol for fourteen months. She has rebuilt her mornings, repaired a strained friendship, and stopped counting the days with anxious precision. One Thursday evening, after a difficult meeting, she walks past a restaurant where she once spent many nights drinking. The smell of the kitchen, the glow of the bar through the window, and the sound of glasses combine into a sudden, physical pull. Her mouth waters, her chest tightens, and a quiet voice suggests that one drink would be harmless, that she has earned it, that nobody would ever know. Within ninety seconds, a person who has felt stable for more than a year is bargaining with herself on a pavement. Whether she walks on, calls a friend, or goes inside will depend less on her willpower in that moment than on what she has learned about craving, what resources she has built, and how she understands what is happening in her own mind.
This scene captures two of the most important and least understood features of substance use disorders: craving and relapse. Craving is the intense desire to use a substance, and it can arise suddenly, long after the last use and in the absence of any physical withdrawal. Relapse is the return to use after a period of abstinence, and it is so common that it is regarded by most clinicians as part of the typical course of recovery and not as proof of failure. Together, these two phenomena explain why substance use disorders are persistent, why they so often seem baffling to families, and why a purely moral or willpower-based view of addiction has proved so unhelpful.
Substance use disorders are common and costly. Surveys in many countries suggest that a substantial minority of adults will meet the criteria for an alcohol or drug use disorder at some point in life. Alcohol, tobacco, opioids, stimulants, cannabis, and sedatives together account for an enormous burden of illness, injury, family distress, and premature death. Yet the majority of people who develop these problems eventually recover, often after several attempts, and the science of why some people recover and others relapse has advanced considerably in recent decades.
This article offers a detailed, evidence-based account of the psychology and neuroscience of substance use disorders, with a focus on craving and relapse. It explains how the disorders are defined, how substances act on the brain’s reward and stress systems, and how learning, memory, and cues create craving. It reviews the stages of addiction, the factors that increase vulnerability, the psychological models of relapse, and the treatments with the strongest evidence, including cognitive behavioral therapy, motivational interviewing, contingency management, mindfulness-based relapse prevention, and medication. It also offers practical strategies for managing urges and preventing relapse, and guidance for families. The central message is that craving and relapse are predictable features of a learned and neurobiological condition, that they can be understood and anticipated, and that recovery is a realistic and common outcome.
What a Substance Use Disorder Is
A substance use disorder is a pattern of use of a psychoactive substance that leads to clinically significant impairment or distress. The word disorder matters. It signals that the problem is not simply heavy use or bad habits, but a condition in which control over use has been compromised, and in which use continues despite clear harm.
The Diagnostic Criteria
According to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, a substance use disorder is diagnosed when a person shows a problematic pattern of use, as indicated by at least two of eleven criteria within a twelve-month period. The criteria fall into four groups. Impaired control includes taking the substance in larger amounts or for longer than intended, persistent unsuccessful efforts to cut down, spending a great deal of time obtaining, using, or recovering from the substance, and craving, which is a strong desire or urge to use. Social impairment includes failure to fulfill major obligations at work, school, or home, continued use despite social or interpersonal problems caused by the substance, and giving up important activities because of use. Risky use includes use in physically hazardous situations and continued use despite knowing that it causes or worsens a physical or psychological problem. Pharmacological criteria include tolerance, the need for more of the substance to achieve the same effect, and withdrawal, the characteristic syndrome that appears when use is reduced or stopped.
Severity is graded as mild with two or three criteria, moderate with four or five, and severe with six or more. The diagnosis applies to specific substances, such as alcohol, opioids, stimulants, cannabis, sedatives, and tobacco, and the specific criteria apply to each in a similar way. It is notable that craving was added as a formal criterion in the fifth edition, reflecting its importance as a core feature of the disorder and as a predictor of relapse.
Use, Misuse, Dependence, and Addiction
The vocabulary in this field is confusing, and the words are often used loosely. Substance use refers to any consumption, which for most people with alcohol or prescribed medication is not a problem. Misuse refers to use that is harmful or not as intended. Physical dependence is a physiological state of adaptation in which the body has adjusted to a substance and shows withdrawal when it is removed, and it can occur without addiction, as in people who take prescribed opioids or benzodiazepines appropriately for long periods. Addiction is the older and broader term for compulsive use despite harm, and it corresponds roughly to a moderate to severe substance use disorder. The distinction between physical dependence and addiction is important: the first is a predictable physical adaptation, while the second is a behavioral and neurobiological disorder of motivation and control.
How Common These Disorders Are
Large national surveys in the United States and Europe suggest that around ten to fifteen percent of adults meet criteria for some substance use disorder in a given year, when alcohol and tobacco are included, and that lifetime rates are considerably higher. Alcohol use disorder is the most common, followed by tobacco and cannabis. Opioid use disorder, though less common, accounts for a large share of overdose deaths. Men are affected more than women in most surveys, although the gap has narrowed in some age groups. The disorders typically begin in adolescence or early adulthood, and early onset of use is associated with greater risk of developing a disorder and a more severe course.
Addiction as a Chronic, Relapsing Condition
A widely cited analysis by Thomas McLellan and colleagues in 2000 compared the course of addiction with that of other chronic illnesses such as type 2 diabetes, hypertension, and asthma. They found that relapse rates after treatment, in the range of forty to sixty percent within a year, were similar to those of these other conditions, and that adherence to treatment and the need for long-term management were similar as well. The conclusion was that addiction should be understood and managed as a chronic condition, with ongoing support and the expectation that relapse may occur, and not as an acute problem to be cured by a single episode of treatment. This framing has been influential, though some researchers note that many people with substance problems recover without long-term treatment and that the chronic disease model should not imply that recovery is rare.
How Substances Act on the Brain
To understand craving and relapse, it helps to understand what psychoactive substances do to the brain. Despite their differences, nearly all drugs of abuse converge on a shared system, the brain’s circuits of motivation and learning.
The Reward Pathway
The central circuit involves dopamine neurons in the ventral tegmental area of the midbrain, which project to the nucleus accumbens in the ventral striatum and to the prefrontal cortex. This mesolimbic pathway evolved to reinforce behaviors that promote survival, such as eating, drinking, and social bonding. Natural rewards produce modest, well-regulated increases in dopamine. Drugs of abuse produce much larger and faster increases. Stimulants such as cocaine and amphetamine directly increase dopamine by blocking its reuptake or promoting its release. Opioids stimulate the pathway indirectly by suppressing inhibitory neurons that normally restrain dopamine cells. Alcohol, nicotine, and cannabis also enhance dopamine activity through various mechanisms. This exaggerated signal teaches the brain that the drug is exceptionally important, and creates a strong, learned drive to seek it.
Wanting and Liking
Research by Kent Berridge and Terry Robinson distinguishes between wanting, the motivational drive to pursue a reward, and liking, the pleasure of consuming it. Dopamine is more closely related to wanting. Their incentive-sensitization theory proposes that repeated drug use sensitizes the wanting system, so that drug-related cues trigger intense craving, even as the pleasure from the drug itself may decline through tolerance. This helps to explain a puzzling feature of addiction: people may crave a drug intensely and keep using it even when they no longer enjoy it much. Sensitization can persist for months or years after last use, which helps to explain why craving can return long after withdrawal has ended.
The Three-Stage Cycle
The neuroscientists George Koob and Nora Volkow have described addiction as a repeating cycle with three stages, each involving different brain regions. In the binge and intoxication stage, the drug activates the reward pathway and the basal ganglia, producing pleasure and, over time, shifting behavior from deliberate to habitual. In the withdrawal and negative affect stage, the extended amygdala becomes involved. When drug use stops, dopamine function falls below normal, and brain stress systems, including corticotropin-releasing factor and dynorphin, become overactive, producing anxiety, irritability, dysphoria, and a reduced capacity to enjoy normal pleasures. In the preoccupation and anticipation stage, the prefrontal cortex, which normally supports planning, judgment, and impulse control, is weakened, and craving is triggered by cues and stress. The cycle intensifies over time, and the motivation for use gradually shifts from seeking pleasure, which is positive reinforcement, to relieving distress, which is negative reinforcement.
The Prefrontal Cortex and Self-Control
The prefrontal cortex acts as the brain’s executive, weighing long-term consequences, inhibiting impulses, and guiding behavior according to goals. Brain imaging studies of people with chronic substance use have found reduced prefrontal activity and reduced gray matter volume in some regions, and impaired performance on tasks measuring decision making, inhibition, and delay of gratification. Volkow and Goldstein have described a model in which drug-related cues produce a surge of motivation, while the prefrontal systems that would normally restrain action are impaired, resulting in a shift from deliberate to compulsive behavior. These changes help to explain why people with severe addiction can sincerely wish to stop and yet find themselves using, and why external structure and support are so valuable.
From Habit to Compulsion
Behavior controlled initially by the expected value of the outcome gradually becomes controlled by cues and routines, shifting from the ventral to the dorsal striatum. The neuroscientist Barry Everitt and Trevor Robbins have proposed that addiction represents a progressive transition from voluntary, goal-directed drug use to habitual and, finally, compulsive use. At the habit stage, a cue such as a place, a person, or a time of day can trigger use almost automatically, without conscious deliberation. This is why a person can find themselves pouring a drink or lighting a cigarette before they have decided to.
Stress Systems
Stress plays a central role in addiction. Chronic substance use alters the hypothalamic-pituitary-adrenal axis and the extrahypothalamic stress systems, making the person more reactive to stress and more prone to craving under pressure. Studies by Rajita Sinha and colleagues have shown that laboratory stress exposure increases craving and predicts relapse in people with cocaine, alcohol, and nicotine dependence. Heightened stress sensitivity can persist for months after abstinence, which is a reason why early recovery is a period of vulnerability and why stress management is a key target of treatment.
Neuroplasticity and Recovery
The brain changes seen in addiction are not permanent. Imaging studies show that, with sustained abstinence, dopamine receptor availability and prefrontal function recover partly, over months to years. A study of methamphetamine users by Volkow and colleagues found substantial recovery of dopamine transporters after fourteen months of abstinence, although some functions recovered more slowly or incompletely. This recovery is encouraging, and it highlights that the early months of abstinence may be a particularly uncomfortable period, as the brain slowly readjusts, and that patience is required.
Craving: The Core of the Problem
Craving is the subjective experience of an urgent desire to use a substance. It is perhaps the most consistently reported feature of addiction and one of the strongest predictors of relapse. Understanding it demystifies much of the behavior of people in recovery.
What Craving Feels Like
Craving can take many forms. It may be an intense, almost physical longing, accompanied by bodily sensations such as salivation, a racing heart, restlessness, and tension. It may be a persistent, intrusive stream of thoughts about the substance, or a vivid mental image of using it. It may be a subtle, background pull that shapes behavior without being clearly noticed. Some people describe craving as a hunger, others as an itch, an emptiness, or a voice. Craving is often accompanied by a narrowing of attention, in which the person becomes preoccupied with the substance and finds it difficult to think of anything else, and by a drop in the value placed on long-term goals. Importantly, craving is not constant. It rises, peaks, and falls, typically over minutes, and its intensity varies with circumstances.
Craving and Withdrawal Are Different
Craving should be distinguished from physical withdrawal. Withdrawal is a physiological syndrome that follows the cessation of a substance, with symptoms such as tremor, sweating, nausea, anxiety, and insomnia, and it usually lasts days to weeks, depending on the substance. Craving can occur during withdrawal, but it can also occur months or years after withdrawal has ended. A person who is physically well may still be gripped by intense craving when exposed to a trigger. This is why detoxification alone is not an effective treatment: it deals with the physical dependence but not with the learned and neurobiological drivers of craving and relapse.
The Role of Cues and Classical Conditioning
One of the most important discoveries about craving is that it is triggered by cues, through classical conditioning. In Pavlov’s experiments, a bell paired repeatedly with food came to produce salivation on its own. Similarly, when drug use is repeatedly paired with particular places, people, moods, objects, and times, those cues come to elicit conditioned responses. Researchers such as Charles O’Brien and Anna Rose Childress showed that people with opioid and cocaine dependence, when shown drug-related images or paraphernalia, experience craving and physiological changes such as altered heart rate and skin conductance, and that brain regions involved in reward and emotion are activated. The cues may be obvious, such as a bar, a syringe, or a dealer’s phone number, or subtle, such as a particular song, a time of day, the smell of smoke, or a feeling of boredom.
Cue reactivity has real clinical significance. Studies show that the strength of cue-induced craving predicts subsequent relapse in several substances. The conditioned responses are remarkably persistent, because extinction of a conditioned response creates a new memory that competes with the old one, instead of erasing it. As a result, craving in response to cues can reappear, a phenomenon related to the spontaneous recovery and renewal seen in fear extinction, especially in a new context or after a stressful event.
Incubation of Craving
Animal research by Marina Wolf, Yavin Shaham, and colleagues has documented a striking phenomenon known as incubation of craving. In rats trained to self-administer cocaine, cue-induced drug seeking does not decline over time after the drug is withdrawn. Instead, it increases over the first weeks of abstinence and remains high for a long period. This finding suggests that neuroadaptations in the brain’s reward circuitry can cause craving to intensify and to persist well into abstinence. Evidence for similar effects in humans is more limited, but reports of cue-induced craving remaining high or even increasing during early abstinence in people recovering from cocaine and nicotine dependence are consistent with it.
Stress-Induced Craving
Craving is triggered not only by drug cues but also by stress and negative emotion. Experimental studies in which people recalled stressful experiences show an increase in craving, heart rate, and stress hormones, together with reduced activity in prefrontal regions. Stress-induced craving appears to depend on different neural circuits from cue-induced craving, particularly involving the extended amygdala and brain stress peptides. This helps to explain why relapse so often follows arguments, loss, financial worry, or loneliness, and why people may use not to feel good but to feel less bad.
Priming: The Effect of a Single Dose
A third trigger is priming, in which a small dose of the drug reinstates craving and drug seeking. In animal studies, a single injection of a drug after a period of extinction can restore drug seeking. In humans, this corresponds to the clinical observation that a single drink or a single use can set off a full relapse, an effect that was described long ago in twelve-step traditions. The priming dose reactivates the sensitized reward system and weakens the brakes on behavior. Together, cues, stress, and priming are the three classic triggers of relapse, identified by Shaham and colleagues in the reinstatement model of relapse.
Cognitive Aspects of Craving
Psychologists have examined how thoughts and mental imagery contribute to craving. The elaborated intrusion theory, proposed by Jon May, Jackie Andrade, and colleagues, holds that craving begins with an intrusive thought triggered by a cue or an internal state, which, if elaborated through vivid imagery and thinking about the substance, produces a strong urge. The elaboration consumes working memory resources and makes the urge more compelling. This theory suggests that tasks that occupy the visual working memory, such as vivid mental imagery of something else or playing a visual game, can reduce craving, and experiments have supported this. It also explains why trying to suppress the thought may be counterproductive, as the research by Daniel Wegner on thought suppression suggests, since suppression tends to make unwanted thoughts return more strongly.
Expectancies and Beliefs
Beliefs about the effects of a substance, known as outcome expectancies, shape craving and use. Someone who strongly believes that alcohol will relieve tension, enhance sociability, or improve sleep is more likely to crave and to drink in situations in which they seek those effects. These expectancies are learned from experience, family, culture, and advertising, and they can be targeted in therapy. The related concept of self-efficacy, a person’s confidence in their ability to resist use in specific situations, is one of the best predictors of success in recovery.
Craving Is Not Destiny
An important lesson of the research is that craving, though powerful, is not irresistible and does not by itself determine behavior. Many people in recovery experience craving and do not use. The urge typically peaks and subsides within minutes to an hour if it is not acted upon, and the frequency and intensity of cravings generally decline over time with sustained abstinence, although occasional strong cravings can occur years later. Understanding that craving is a conditioned response, an expected feature of the condition, and a wave that passes can transform the way a person experiences it, turning it from a sign of failure into a signal to use a skill.
Why People Develop Substance Use Disorders
Most people who try alcohol or other drugs do not develop a disorder. A central question is why a minority do, and the answer involves many interacting factors.
Genetic Vulnerability
Twin and adoption studies show that substance use disorders are substantially heritable, with estimates from about forty to seventy percent depending on the substance, with higher estimates for cocaine and opioids and somewhat lower for cannabis and hallucinogens. Genes influence addiction through many pathways, including how a person metabolizes a drug, how rewarding or aversive the drug feels, impulsivity, stress reactivity, and the risk of other psychiatric conditions. A well-known example is a variant in the genes that metabolize alcohol, common in East Asian populations, which causes unpleasant flushing and protects against alcoholism. No single gene determines addiction, and genetic risk is a matter of probability and not destiny.
Developmental Timing
Adolescence is a period of heightened vulnerability. The brain systems of reward and emotion mature earlier than the prefrontal systems of control, which continue to develop until the mid-twenties, creating a period of high sensation seeking and relatively limited self-regulation. Studies consistently find that the earlier a person begins to use alcohol or drugs, the greater the risk of later disorder. Early use may reflect pre-existing vulnerability, and may also interfere with brain development and increase the likelihood of dependence.
Childhood Adversity and Trauma
Adverse childhood experiences, including abuse, neglect, household dysfunction, and parental substance use, are strongly associated with later substance use disorders. The Adverse Childhood Experiences study, led by Vincent Felitti and Robert Anda, found a graded relationship between the number of adverse experiences and the risk of alcoholism, drug use, and injection drug use, with those with multiple adversities showing several times the risk. Trauma can sensitize stress systems and impair emotion regulation, and substances may be used to cope with intrusive memories and distress. Post-traumatic stress disorder and substance use disorders frequently co-occur, and treating them together is increasingly recognized as important.
Mental Health Conditions and Self-Medication
Substance use disorders frequently co-occur with other mental health conditions, such as depression, anxiety disorders, bipolar disorder, attention-deficit hyperactivity disorder, personality disorders, and psychotic disorders. The relationship is complex and works in both directions. Some people use substances to relieve symptoms, which is the self-medication hypothesis proposed by Edward Khantzian, who argued that people select substances that fit their particular emotional pains: opioids to soothe rage and distress, stimulants to counter depression and low energy, and depressants to calm anxiety. Substance use may also cause or worsen mental illness, and the two conditions may share underlying risk factors. Integrated treatment of both is more effective than treating either alone.
Personality and Temperament
Certain traits increase risk. Impulsivity, sensation seeking, and a tendency toward behavioral disinhibition are associated with early and heavy use. Negative emotionality, including anxiety sensitivity and a tendency to experience distress, increases risk of use to cope. The personality model developed by Patricia Conrod and colleagues identifies four risk profiles, impulsivity, sensation seeking, anxiety sensitivity, and hopelessness, which predict different patterns of use and respond to targeted interventions, as shown in school-based prevention trials.
Learning and Social Environment
Social learning shapes use. Peers who use, family members who use, and cultural norms that accept heavy use all increase risk. Availability and price are important: public health research consistently shows that higher taxes on alcohol and tobacco and restrictions on availability reduce consumption and harm. Neighborhood disadvantage, unemployment, and social isolation are associated with higher rates of disorders, and the loss of social connection is a recurrent theme in the experiences of people with addiction.
The Role of Pain and Prescription Medication
The opioid crisis has highlighted the role of prescribed medication. Most people who take opioids for pain do not develop addiction, but a minority do, and the risk rises with higher doses, longer duration, a history of substance use or mental illness, and certain social circumstances. Chronic pain and substance use disorders often co-occur, and treatment requires attention to both. The broader lesson is that addiction can develop in people with no prior history of problems, and that access and context matter.
The Rat Park and the Importance of Environment
In the 1970s, the psychologist Bruce Alexander conducted experiments in which rats housed in a spacious, enriched environment with social contact, called Rat Park, consumed far less morphine solution than rats housed alone in small cages. The experiments were widely cited as evidence that addiction is driven by environment and isolation rather than by the drug alone. They have been criticized on methodological grounds, and replication has been mixed, so they should not be taken as proof. Nonetheless, the broader literature supports the idea that social connection, meaningful activity, and a stimulating environment protect against addiction and aid recovery, and that isolation and deprivation increase risk.
The Psychology of Relapse
Relapse is the resumption of substance use after a period of abstinence. It is common, and understanding its psychology is central to preventing it. Researchers have long distinguished between a lapse, a single episode of use, and a relapse, a return to the previous pattern of use, and the distinction is clinically important, because how a person responds to a lapse often determines whether it becomes a relapse.
How Common Relapse Is
Studies of treated populations find that roughly forty to sixty percent of people return to some use within a year of treatment, with the highest risk in the first weeks and months. The risk declines with time: people who have remained abstinent for a year are far less likely to relapse than those at three months, and after five years of continuous remission, the likelihood of future relapse falls to a level close to that of the general population, according to a study by Michael Dennis and colleagues. Relapse rates vary by substance, being particularly high for tobacco, heroin, and alcohol in some samples. These figures describe average patterns, and individuals differ greatly.
The Cognitive-Behavioral Model of Relapse
The most influential psychological model was developed by G. Alan Marlatt and Judith Gordon, who studied relapse in alcohol, tobacco, and other drug use. They identified high-risk situations, circumstances in which a person’s sense of control is threatened and the likelihood of use is high. Their analysis of relapse episodes found that the most common triggers were negative emotional states, such as anger, frustration, depression, and anxiety, accounting for about a third of relapses, interpersonal conflict, accounting for about a sixth, and social pressure to use, accounting for about a fifth. Positive emotional states and the testing of personal control were also notable.
According to the model, if a person has effective coping strategies for the high-risk situation, such as walking away, using a relaxation technique, calling a friend, or refusing assertively, self-efficacy increases and the probability of relapse falls. If the person lacks such strategies, self-efficacy declines, the expectation of positive effects from the substance rises, and the chance of a lapse increases. The model also describes the abstinence violation effect, in which, after a lapse, the person experiences guilt, shame, and a sense of failure, and attributes the lapse to personal weakness. The all-or-nothing belief that abstinence is already broken, so that nothing further is lost by continuing, can transform a single lapse into a full relapse. This effect is particularly relevant to the marked difference between abstinence-based approaches that treat any use as a failure and approaches that treat a lapse as an opportunity to learn.
The Relapse Process as a Gradual Chain
Terence Gorski and others have described relapse not as a sudden event but as a process that begins well before actual use, with changes in thoughts, emotions, and behavior. Early warning signs may include growing stress, isolation, neglect of recovery routines, return of old thinking patterns such as minimizing the problem or romanticizing past use, irritability, dishonesty, and the dropping of supports. By the time a person reaches the high-risk situation, the chain of choices that led there is often long. The idea of seemingly irrelevant decisions, such as taking a different route that passes a bar or accepting an invitation to a gathering where drinking occurs, shows how the relapse process can begin without the person recognizing it. This view underlies the emphasis on identifying early warning signs and on lifestyle balance.
Stages of Change and Relapse
The transtheoretical model, developed by James Prochaska and Carlo DiClemente, describes change as a progression through stages: precontemplation, in which the person is not considering change, contemplation, in which they are ambivalent, preparation, action, and maintenance. They observed that people typically cycle through the stages several times before achieving lasting change, and that relapse is a common part of the process. People who relapse generally do not return to the beginning but to an earlier stage, and many learn from the experience. This model has influenced the approach of treatment providers, who match interventions to the person’s readiness and see relapse as an expected event.
Common Triggers and High-Risk Situations
While individual triggers vary, certain categories recur across studies. Emotional triggers include stress, anger, sadness, loneliness, boredom, and anxiety. Social triggers include contact with people who use, conflict with partners or family, and social pressure. Environmental triggers include places where use occurred, the presence of the substance, and paraphernalia. Physical triggers include pain, illness, fatigue, and the effects of poor sleep, hunger, and, in some cases, protracted withdrawal symptoms. Celebration and positive emotion can trigger relapse as well, as when a person feels confident and decides they can handle a single drink. Life transitions, such as a job loss, a breakup, a bereavement, or the achievement of a long-sought goal, are periods of heightened risk.
Protracted Withdrawal
Some people experience a prolonged phase of lingering symptoms after acute withdrawal, often called protracted withdrawal or post-acute withdrawal syndrome. Symptoms may include anxiety, irritability, low mood, sleep disturbance, poor concentration, anhedonia, and fluctuating cravings, and they can persist for weeks to months, depending on the substance. The concept is clinically useful, although its scientific status and the exact range of symptoms are debated. These symptoms reflect the slow recovery of brain stress and reward systems, and they can be misinterpreted as proof that the person cannot be happy without the substance, a belief that can precipitate relapse. Knowing that they are temporary can help.
Decision Making, Delay Discounting, and the Hot-Cold Gap
Behavioral economics offers a further perspective. People with substance use disorders show steeper delay discounting, a preference for smaller immediate rewards over larger delayed ones, as demonstrated by researchers such as Warren Bickel. Studies find that steep discounting predicts poorer treatment outcomes and a higher risk of relapse. Related is the concept of the hot-cold empathy gap, described by George Loewenstein, the difficulty of predicting one’s behavior in a state of craving from the standpoint of a calm state. When calm, a person sincerely believes that they will not use. When in the grip of craving, judgment shifts, and the value placed on immediate relief rises. This is why planning in advance, while calm, is so important, and why arranging the environment so that fewer decisions are required at the moment of craving is effective.
Relapse as Learning
Relapse, though painful and sometimes dangerous, can be informative. Each episode can reveal triggers that were underestimated, coping skills that were lacking, or supports that were absent. People who treat a relapse with curiosity, asking what happened, which warning signs were missed, and what to change, are more likely to recover than those who respond with shame. This does not mean that relapse is harmless: for substances such as opioids, relapse after a period of abstinence carries a risk of fatal overdose because tolerance has fallen, a danger that is discussed below. The aim is to prevent relapse where possible and to minimize harm and return quickly to recovery when it occurs.
Substances and Their Specific Patterns
While the psychology of craving and relapse is similar across substances, each class has particular features. A brief review helps to illustrate the range, bearing in mind that this is not guidance on use.
Alcohol
Alcohol use disorder is the most common substance use disorder. Alcohol acts on gamma-aminobutyric acid and glutamate systems as well as dopamine and opioid systems. Severe dependence can produce dangerous withdrawal, including seizures and delirium tremens, so people with heavy daily use should seek medical supervision before stopping suddenly. Craving is strongly cue-driven and mood-driven, and the abstinence violation effect is common. Medication options and effective psychological treatments exist, and many people achieve long-term recovery.
Opioids
Opioid use disorder, involving heroin, fentanyl, and prescription opioids, is characterized by severe withdrawal, strong craving, and a high risk of relapse and overdose. After a period of abstinence, tolerance falls, so a return to the previous dose can be fatal. Medications for opioid use disorder, namely methadone, buprenorphine, and naltrexone, reduce craving, prevent withdrawal, and substantially lower the risk of death, and they are regarded as the standard of care. Evidence indicates that people maintained on these medications have far lower mortality than those who attempt abstinence without medication, and that stopping them is associated with high relapse rates.
Stimulants
Cocaine and methamphetamine produce intense dopamine surges and, with repeated use, profound changes in reward and stress systems. Withdrawal is less physically dangerous than that of alcohol or opioids, but is marked by depression, fatigue, anhedonia, and intense craving. Cue-induced craving is particularly strong, and the incubation phenomenon has been demonstrated for cocaine. No medication has been approved for stimulant use disorder, and treatment relies largely on psychosocial approaches, particularly contingency management, which has the strongest evidence.
Cannabis
Cannabis use disorder affects a substantial minority of regular users, with higher risk among those who begin in adolescence, use daily, and use high-potency products. A withdrawal syndrome of irritability, sleep disturbance, decreased appetite, and anxiety is common. No approved medication exists, and treatment relies on cognitive behavioral therapy, motivational enhancement, and contingency management.
Nicotine and Tobacco
Nicotine is among the most addictive substances, and tobacco use remains a leading cause of preventable death. Most smokers want to quit, and most attempt several times before succeeding. Craving is strongly cue-driven, and relapse is highest in the first days and weeks. Effective treatments include nicotine replacement therapy, varenicline, bupropion, and behavioral support, and combining medication with counseling improves success rates substantially.
Sedatives and Benzodiazepines
Sedatives such as benzodiazepines can cause physical dependence with regular use, even when taken as prescribed, and abrupt discontinuation can produce dangerous withdrawal, including seizures. Tapering under medical supervision is essential. Psychological support, particularly cognitive behavioral therapy for the condition for which the drug was prescribed, improves outcomes.
Polysubstance Use
Many people use more than one substance, and alcohol, tobacco, and cannabis frequently accompany other drugs. Combining substances increases risks, particularly overdose when depressants such as alcohol, opioids, and benzodiazepines are combined. Treatment needs to take account of all substances used.
Treatment: What the Evidence Supports
Substance use disorders respond to treatment. Although relapse is common, studies consistently show that treatment reduces use, improves health and functioning, reduces crime, and saves money compared with no treatment. The most effective care is individualized and combines psychological, medical, and social elements, and it is provided over a sufficient period.
Assessment and Matching Treatment to Need
Treatment begins with a thorough assessment of substances used, severity, withdrawal risk, medical and psychiatric conditions, social circumstances, and readiness for change. Standardized levels of care, such as those defined by the American Society of Addiction Medicine, range from early intervention and outpatient treatment to intensive outpatient, residential, and medically managed inpatient care. Matching the intensity of treatment to the severity of the problem, and adjusting it as the person progresses, is a principle of good care.
Medical Detoxification
Where there is a risk of dangerous withdrawal, as with alcohol, benzodiazepines, and opioids, medically supervised detoxification is essential. It is, however, only the first step. Studies show that detoxification alone has little effect on long-term outcomes, and that people who leave treatment after detoxification without further care typically relapse. Linking detoxification to continuing treatment is therefore essential.
Motivational Interviewing and Motivational Enhancement
Motivational interviewing, developed by William Miller and Stephen Rollnick, is a collaborative, empathic style of conversation designed to strengthen a person’s own motivation for change and to resolve ambivalence. The therapist avoids confrontation, expresses empathy, helps the person to see the gap between their behavior and their values, rolls with resistance, and supports self-efficacy. Meta-analyses show that it produces significant, if modest, reductions in substance use, and it is especially effective in engaging people who are reluctant, including adolescents. Brief interventions based on this approach, delivered in primary care, are effective in reducing hazardous drinking.
Cognitive Behavioral Therapy and Relapse Prevention
Cognitive behavioral therapy is one of the best-studied treatments for substance use disorders. It teaches people to identify the thoughts, feelings, and situations that trigger use, to challenge beliefs that maintain it, and to develop coping skills. Relapse prevention, the program developed by Marlatt and Gordon, is a cognitive behavioral approach that explicitly focuses on high-risk situations, coping responses, self-efficacy, lifestyle balance, and the management of lapses. Typical components include functional analysis of use, which examines the antecedents and consequences of each episode, skills training in coping with craving, refusal skills, problem solving, mood management, and planning for emergencies. Meta-analyses show that cognitive behavioral therapy has moderate effects on substance use, with effects that often increase after treatment ends, a delayed emergence sometimes called the sleeper effect, as people continue to apply the skills.
Contingency Management
Contingency management is a behavioral treatment in which people receive tangible rewards, such as vouchers or small prizes, for objectively verified abstinence, typically measured by drug testing. Grounded in operant conditioning, it directly counters the problem of delay discounting by providing immediate, reliable reward for abstinence. Research by Stephen Higgins and colleagues, and many subsequent trials and meta-analyses, show that it is one of the most effective treatments for stimulant, cannabis, opioid, and tobacco use disorders, and it is the best-supported psychosocial treatment for stimulant use disorder, for which no medication exists. The effects tend to last for as long as the incentives are in place and sometimes beyond. It has been underused for reasons related to concerns about paying people for what they should do anyway, though evidence and cost-effectiveness arguments have led to its adoption in several health systems.
Mindfulness-Based Relapse Prevention
Mindfulness-based relapse prevention, developed by Sarah Bowen, Alan Marlatt, and colleagues, combines cognitive behavioral relapse prevention with mindfulness meditation. Participants learn to observe cravings, thoughts, and emotions with awareness and without judgment, a skill sometimes called urge surfing, in which an urge is observed rising, peaking, and falling like an ocean wave. The aim is to interrupt the automatic link between trigger and use. Randomized trials have found that it reduces relapse to substance use and heavy drinking compared with treatment as usual, with benefits that become more evident over a year, though effects compared with standard relapse prevention are similar in some studies. Mindfulness also helps with the stress and negative emotion that drive relapse.
Acceptance and Commitment Therapy and Dialectical Behavior Therapy
Acceptance and commitment therapy helps people to accept unwanted thoughts and feelings, including craving, without struggling against them and to commit to actions in line with their values. Dialectical behavior therapy, with its emphasis on distress tolerance and emotion regulation, has been adapted for people with substance use disorders, particularly those with borderline personality features. Both have supporting evidence, though trials are smaller than for cognitive behavioral therapy.
The Community Reinforcement Approach and Family Involvement
The community reinforcement approach, developed by Nathan Azrin and Robert Meyers, aims to rearrange a person’s life so that sober living is more rewarding than substance use, by addressing employment, relationships, recreation, and social support. Its variant for families, community reinforcement and family training, teaches relatives communication, positive reinforcement of sobriety, and ways of encouraging the person to enter treatment, and has been shown to engage substantially more resistant people into treatment than confrontational interventions or referral to family support groups. Couple and family therapies, including behavioral couples therapy, improve outcomes and relationships, and multidimensional family therapy is effective for adolescents.
Twelve-Step Facilitation and Mutual Aid Groups
Alcoholics Anonymous, founded in 1935, and the related fellowships Narcotics Anonymous and others, are the most widely used sources of support. Their program of mutual support, sponsorship, and spiritual principles has helped millions. A Cochrane review led by John Kelly and colleagues in 2020 concluded that clinically delivered twelve-step facilitation was as effective as other established treatments, such as cognitive behavioral therapy, in producing abstinence, and often more effective for continuous abstinence, with lower health care costs. Attendance is associated with better outcomes, though self-selection complicates interpretation. Alternatives for those who prefer a secular approach include SMART Recovery, which is based on cognitive behavioral principles, LifeRing, and Women for Sobriety. The best group is the one that a person will attend.
Medications for Alcohol Use Disorder
Three medications are widely approved for alcohol use disorder. Naltrexone, an opioid antagonist, reduces the rewarding effect of alcohol and craving, and decreases heavy drinking and relapse. Acamprosate is thought to modulate glutamate and to ease protracted withdrawal symptoms, and supports the maintenance of abstinence. Disulfiram causes an unpleasant reaction when alcohol is consumed and works best with supervised administration. Other medications, such as topiramate and gabapentin, have some evidence. Medications for alcohol use disorder are underused, despite evidence of benefit, and are most effective when combined with psychosocial support.
Medications for Opioid Use Disorder
Methadone, a full opioid agonist, and buprenorphine, a partial agonist, stabilize the brain’s opioid system, prevent withdrawal, reduce craving, and block the effects of other opioids, and they reduce overdose death, infectious disease transmission, and criminal activity. Naltrexone, as a long-acting injection, blocks the effects of opioids and is an option for those who have completed detoxification. Large studies show that retention in treatment with methadone or buprenorphine is associated with markedly reduced mortality. The misperception that these medications simply replace one addiction with another is not supported by evidence, since they allow people to function, work, and rebuild relationships. Naloxone, which reverses opioid overdose, should be available to people who use opioids and their families.
Medications for Tobacco Use Disorder
Nicotine replacement therapy, including patches, gum, lozenges, inhalers, and sprays, approximately increases the chance of quitting by half to double. Varenicline, which partially stimulates nicotine receptors and blocks the effect of nicotine, is among the most effective, and bupropion also helps. Combining a patch with a short-acting form of nicotine replacement, or medication with behavioral counseling, improves success rates further. Stopping smoking is among the most beneficial things a person can do for health at any age.
Emerging and Experimental Treatments
Research continues into new approaches. Glucagon-like peptide-1 receptor agonists, used for diabetes and obesity, have shown early signals of reducing alcohol and other substance cravings in observational and early trials, and larger trials are under way. Psychedelic-assisted therapy has been studied for alcohol, tobacco, and other use disorders with promising preliminary results, but remains experimental. Transcranial magnetic stimulation has received regulatory clearance for smoking cessation in some countries and is being studied for other substances. Vaccines against cocaine and nicotine have not yet proved effective. These developments are of interest but do not replace established treatment.
Treating Co-Occurring Conditions
Because mental health conditions are so common in people with substance use disorders, integrated treatment, in which both are addressed together by a coordinated team, is recommended. Untreated depression, anxiety, trauma, or attention-deficit hyperactivity disorder increases relapse risk. Specific treatments, such as trauma-focused therapies adapted for substance use, medication for depression, and treatment of attention disorders with appropriate medication or behavioral therapy, are part of care.
Harm Reduction
Harm reduction is an approach that aims to reduce the negative consequences of substance use without requiring abstinence as a precondition. Examples include syringe services programs, naloxone distribution, supervised consumption sites in some countries, drug-checking services, safer use education, and medication for opioid use disorder. Evidence shows that harm reduction reduces overdose deaths and the spread of infection and does not increase drug use, and that it keeps people connected to services and can lead to treatment. Many clinicians regard harm reduction and abstinence-oriented treatment as complementary, meeting people where they are.
Length and Continuity of Care
The length of treatment is important. Studies show that outcomes improve with longer retention, and that continuing care, including follow-up contacts, recovery check-ups, and ongoing mutual aid, improves long-term outcomes. A recovery management model, which treats addiction as a chronic condition requiring monitoring and support over years, has been advocated by William White and others. Brief episodes of care, without follow-up, are associated with high rates of relapse.
Practical Strategies for Managing Craving and Preventing Relapse
Professional help is advisable for a substance use disorder, and the strategies below do not replace it. They are drawn from the evidence-based approaches described above and may help people in treatment or in recovery. Anyone who is physically dependent on alcohol, benzodiazepines, or opioids should not stop suddenly without medical advice, since withdrawal can be dangerous. In an emergency, such as suspected overdose, contact emergency services immediately.
Know That Craving Is Temporary
Urges rise, peak, and fall, usually within twenty to thirty minutes. Remind yourself that craving is a conditioned response, an expected feature of recovery, and not a command. Try to treat the urge as a wave: notice where it is felt in the body, describe it without judgment, and observe as it crests and recedes. Urge surfing, a technique from mindfulness-based relapse prevention, trains this skill.
Use the Delay, Distract, Decide Approach
When an urge arises, delay acting on it for at least fifteen to thirty minutes. During that time, distract yourself with an absorbing activity: a walk, a shower, exercise, a phone call, a task requiring concentration. Research on elaborated intrusion suggests that activities that occupy visual working memory can reduce the vividness of craving. After the delay, decide with a clear mind. Often the urge has passed.
Identify Triggers and Make a Plan
Keep a record of situations, emotions, people, places, and times that preceded urges or use. Group them into categories, such as emotional, social, environmental, and physical. For each, create a specific plan. For example, if payday is a trigger, arrange for a companion or a different routine, and if loneliness on Friday evenings is a trigger, plan a regular activity with sober friends. Rehearse the plan, as plans made in advance are far more likely to be used in the moment than ones improvised under pressure.
Change the Environment
Remove substances and paraphernalia from the home, delete contacts, avoid places associated with use, and reduce exposure to cues, particularly in early recovery. The aim is to reduce the number of decisions that must be made under craving. Over time, with stronger skills, some exposure to cues may be manageable and even therapeutic, but this is best done with guidance.
Manage Stress and Emotions
Because stress and negative emotions are leading triggers, building skills to manage them is essential. Regular exercise, sleep, relaxation techniques, slow breathing, mindfulness, journaling, and talking to a trusted person all help. For persistent depression, anxiety, or trauma symptoms, treatment is important. Recognize the acronym often used in recovery programs, HALT, which stands for hungry, angry, lonely, and tired, as a reminder that basic needs and states affect vulnerability.
Prepare Refusal Skills
Social pressure and offers of substances are inevitable. Prepare short, firm statements, such as “No, thanks, I don’t drink,” and practice them aloud. Decide in advance which situations to avoid and which to attend with an exit plan, a supportive companion, and a non-alcoholic drink in hand. It is not rude to leave an event that is risky.
Challenge Thoughts That Lead to Use
Learn to recognize permission-giving thoughts, such as “One won’t hurt,” “I deserve a reward,” “I can control it now,” and “Nobody will know.” Write down the evidence against them and recall the consequences of previous use. Remind yourself of the reasons for change, and keep a list of them in a place where you can reach it. Surf past the romanticized memory of use by recalling the full picture, including the costs.
Build a Life Worth Staying Sober For
Recovery is more than the absence of use. It involves building a life with meaningful activity, connection, and purpose, which gives the brain alternative sources of reward and gives the person reasons to protect their recovery. Research on recovery capital, the resources available to a person, including social support, housing, employment, and personal strengths, shows that it predicts sustained recovery. Reconnecting with family, forming sober friendships, taking up exercise, creative work, education, or volunteering, and finding a spiritual or philosophical framework, if meaningful, all contribute.
Stay Connected to Support
Isolation increases risk. Attend meetings or counseling regularly, keep in contact with a sponsor, peer, or counselor, and tell trusted people about early warning signs. Many people find that peer support, from people who have had the same experience, provides understanding and accountability that others cannot. Recovery coaches, online communities, and recovery community centers are increasingly available.
Plan for a Lapse
A realistic plan includes what to do if a lapse occurs. A written plan might say: stop, leave the situation, contact a named person, and return to support within twenty-four hours. Treat a lapse as information, not proof of failure, and avoid the abstinence violation effect by reminding yourself that one lapse is not a relapse unless you allow it to be. People who have been abstinent from opioids should be aware that tolerance has fallen and that a return to a former dose may be fatal. Keeping naloxone available and ensuring that others know how to use it saves lives.
Take Care of Your Health
Sleep, nutrition, exercise, and medical care support the brain’s recovery. Regular exercise reduces craving and improves mood, and studies suggest that it can reduce cravings for nicotine and other substances. Attend to dental, medical, and psychiatric needs, which may have been neglected.
Supporting a Family Member or Friend
Living with someone who has a substance use disorder is exhausting and frightening. Family members often cycle through hope, anger, fear, and exhaustion, and they carry their own burden of illness and distress. Their role can be significant, and so can their need for support.
Understand the Condition
Learning that substance use disorders involve changes in the brain’s motivation and control systems, that craving is a conditioned response, and that relapse is common can reduce the sense of personal betrayal. It does not excuse harmful behavior, and it does not mean that the person is not responsible for their recovery, but it provides a more accurate and compassionate frame than the view that addiction is simply a choice or a lack of love.
Communicate With Empathy and Honesty
Choose a calm moment, avoid accusations and labels, describe specific behavior and your feelings, express care and concern, and listen. Avoid lectures and ultimatums unless you are prepared to follow through. Motivational interviewing principles, such as reflective listening and eliciting the person’s own reasons for change, are more effective than confrontation. Community reinforcement and family training programs teach these skills.
Do Not Enable, and Do Not Abandon
Enabling means shielding the person from the consequences of use, for example by covering for them, paying their debts, or making excuses. Withdrawing such protection can motivate change, but it should be done with care and love, not as punishment. At the same time, cutting off all contact is rarely necessary and may remove an important source of support, except where safety demands it. A balance between support for recovery and refusal to support the addiction is the aim.
Respond Wisely to Relapse
When relapse occurs, avoid despair, blame, and the assumption that all progress is lost. Express concern, remind the person of their strengths and previous progress, and encourage a rapid return to treatment and support. Keep naloxone available if opioids are involved. A calm, supportive response reduces shame and makes it easier for the person to seek help.
Protect Safety
If there is violence, threats, or risk to children, safety comes first. Contact emergency services, domestic violence services, or child protection as necessary. In case of suspected overdose, call emergency services immediately and, for opioids, give naloxone if available.
Look After Yourself
Relatives often experience anxiety, depression, and physical illness, and many benefit from counseling and from mutual support groups such as Al-Anon, Nar-Anon, and SMART Recovery Family and Friends. Maintaining your own friendships, interests, and health is not selfish, and it enables you to sustain support. You are not responsible for causing, controlling, or curing the addiction.
Stigma, Language, and Respect
Stigma is one of the major barriers to treatment. Research by John Kelly and colleagues has shown that terms such as addict, substance abuser, and clean or dirty carry negative connotations and can influence attitudes, including those of clinicians, toward people with the condition. Person-first language, such as a person with a substance use disorder, and neutral terms, such as returning to use, in remission, or toxicology result positive, are recommended by many health organizations. Describing the condition as a health problem and not a moral failing makes it easier for people to seek help. At the same time, accountability for harmful behavior remains important, and recognizing a disorder does not remove responsibility for recovery or for repairing harm.
Common Myths About Craving and Relapse
Several persistent misconceptions hamper understanding and recovery. The first is that addiction is simply a lack of willpower. Substances alter the brain’s motivation and control systems, and craving, cue reactivity, and stress sensitivity make resisting use difficult, so that effective help provides structure and skills as well as determination. The second is that relapse means treatment has failed. Relapse rates for addiction resemble those of other chronic conditions, and many people who relapse go on to recover. The third is that detoxification is a cure. It addresses physical dependence and not the learned and neurobiological drivers of craving.
A fourth myth is that people must hit rock bottom before they can recover. Research shows that earlier intervention produces better outcomes, and that coerced or pressured treatment can be as effective as voluntary treatment. A fifth is that medication for opioid or alcohol use disorder is simply substituting one drug for another. The evidence shows that these medications reduce mortality, improve functioning, and support recovery. A sixth is that craving will last forever. For most people, craving decreases over time, though occasional strong urges may occur. A seventh is that one lapse destroys all progress. Lapses are common, and how a person responds determines the outcome. An eighth is that a person must be abstinent from everything to be in recovery. Definitions of recovery vary, and many people reduce use or move to safer patterns as steps toward abstinence, though for some substances and some people abstinence is the safest goal. A ninth is that only certain kinds of people develop addiction. Substance use disorders occur across all social groups, ages, and professions.
A Realistic and Hopeful Outlook
The long-term outlook for people with substance use disorders is much better than public perception suggests. Large national surveys indicate that a majority of people who ever met criteria for a substance use disorder eventually achieve remission, and that most do so without formal treatment, though people with more severe disorders are likelier to need help. Studies of the course of recovery find that it usually takes several attempts, and that the probability of sustained remission increases with each year of abstinence. The research by Dennis and colleagues indicated that, on average, it takes about three to four episodes of treatment and some years before stable recovery is reached, and that after about five years of continuous abstinence the risk of relapse falls to a low level.
Recovery is also more than the end of substance use. People in recovery report improvements in health, relationships, employment, self-respect, and sense of purpose. The concept of recovery capital reminds us that these gains, in turn, strengthen the foundation for continuing recovery. Many people in long-term recovery describe their experience as the beginning of a more authentic life, and many become sources of support for others. Society benefits as well: treatment pays for itself several times over in reduced health care, crime, and lost productivity costs.
When to Seek Help
It is time to seek help if substance use is causing harm, if the person has been unable to cut down, if craving is dominating thoughts, if use is continuing despite problems with health, relationships, work, or the law, or if relapse has occurred after a period of abstinence. A good first step is to see a general practitioner, an addiction specialist, or a mental health professional, or to contact a national helpline, which in many countries is free, confidential, and available at all hours. People who are physically dependent should seek medical advice before stopping. Anyone who has thoughts of suicide, or who has overdosed or witnesses an overdose, should contact emergency services immediately. Seeking help after a relapse is as appropriate as seeking it at the beginning.
Conclusion
Craving and relapse lie at the heart of substance use disorders. Substances capture the brain’s motivation and learning systems, producing a sensitized wanting that is triggered by cues, stress, and a single dose, long after the body has recovered from withdrawal. At the same time, the prefrontal systems that normally support control are weakened, and decisions shift in favor of immediate relief. Relapse follows when high-risk situations meet inadequate coping, falling self-efficacy, and the shame of a lapse, and it often develops gradually through a chain of small choices. These are predictable processes, not signs of moral weakness.
Understanding them opens practical paths. Cognitive behavioral therapy and relapse prevention teach people to anticipate triggers and respond skillfully, motivational interviewing strengthens the person’s own reasons for change, contingency management supplies the immediate rewards that the addicted brain demands, mindfulness helps people ride out urges, and medications for alcohol, opioid, and tobacco use disorders reduce craving and save lives. Mutual aid groups and a rebuilt life of connection and purpose sustain recovery over time. Family members can help by learning about the condition, communicating with empathy, refusing to enable, responding calmly to relapse, and taking care of themselves. Anyone struggling with substance use, or who is concerned about someone else, is encouraged to speak with a doctor, a counselor, or a helpline, and to seek emergency help in a crisis. Craving is a wave, and relapse is a risk but not a verdict. With knowledge, skills, and support, most people who have lost control of their use can learn to regain it.
FAQ About Craving, Relapse, and Substance Use Disorders
What causes cravings, and why do they come back after months of sobriety?
Cravings arise from learned associations and changes in the brain’s reward, stress, and control systems. Repeated use pairs the substance with cues such as places, people, moods, and times of day, so that those cues alone can trigger conditioned craving through classical conditioning. Drugs also sensitize the brain’s wanting system, so that cues provoke strong motivation, and they alter stress systems, so that distress triggers urges. Extinguishing these associations creates a new memory that competes with the old one and does not erase it, which means that craving can return in a new context, after stress, or after a lapse. Frequency and intensity generally decline over time, but occasional strong cravings can occur years into recovery, and having skills to manage them is important.
How long does craving last?
An individual urge typically rises, peaks, and subsides within about twenty to thirty minutes if it is not acted on, and often sooner. Over weeks and months of abstinence, cravings generally become less frequent and less intense, although the pattern varies by substance and person, and some people experience periods of heightened craving in response to stress or cues. Protracted withdrawal symptoms, such as low mood, anxiety, and sleep disturbance, can persist for weeks to months and may be associated with fluctuating cravings. Knowing that cravings are temporary, and using techniques such as delay, distraction, and urge surfing, helps people to get through them.
Is relapse a sign that treatment has failed?
No. Relapse rates for substance use disorders, around forty to sixty percent within a year of treatment, are similar to those for other chronic conditions such as hypertension and asthma, and relapse is regarded by clinicians as a common part of the course of recovery. It usually signals that the treatment plan needs adjusting, for example by increasing support, addressing a trigger, or adding medication, and not that the person is hopeless. Many people who relapse return to treatment and achieve sustained recovery, and the likelihood of lasting remission rises with time. The important thing is to respond quickly and without shame. For opioids, relapse carries a risk of overdose because tolerance falls, so safety measures such as naloxone are important.
What is the difference between a lapse and a relapse?
A lapse is a single episode of use after a period of abstinence, while a relapse is a return to the previous pattern of regular use. The distinction matters because a lapse need not become a relapse. According to the cognitive-behavioral model, how a person interprets the lapse is crucial. The abstinence violation effect, in which guilt and the belief that all progress is lost lead to further use, can transform a lapse into a relapse. People who treat a lapse as a learning experience, identify what triggered it, and quickly return to their plan and support are less likely to relapse fully. Having a written plan for a lapse in advance is helpful.
Is addiction a disease or a choice?
The question presents a false dichotomy. Initial use is usually voluntary, but repeated use of addictive substances changes the brain’s reward, stress, and control systems in ways that undermine voluntary control, particularly in vulnerable people, and addiction is therefore recognized as a medical condition, a chronic, relapsing disorder of motivation and self-control. At the same time, people with addictions retain the capacity to make choices, to respond to incentives and support, and to take steps toward recovery, which is why treatments such as contingency management and motivational interviewing work. The most useful view recognizes both biological vulnerability and personal agency, and holds people responsible for their actions while providing effective treatment.
What are the most effective treatments for substance use disorders?
Effective treatment is usually a combination tailored to the person. Evidence supports cognitive behavioral therapy and relapse prevention, motivational interviewing, contingency management, mindfulness-based relapse prevention, twelve-step facilitation and mutual aid groups, and family-based approaches. Medications are effective for several disorders: naltrexone, acamprosate, and disulfiram for alcohol, methadone, buprenorphine, and naltrexone for opioids, and nicotine replacement, varenicline, and bupropion for tobacco. For stimulants and cannabis, no medication is approved, and behavioral treatment, especially contingency management, is the mainstay. Co-occurring mental health conditions should be treated at the same time, and longer treatment with continuing care yields better outcomes.
Are medications like methadone and buprenorphine just replacing one addiction with another?
No. These medications act on the same receptors as other opioids but, when properly prescribed, stabilize the brain, prevent withdrawal, reduce craving, and block the effects of illicit opioids, without the cycle of intoxication and withdrawal. Studies consistently show that people who receive them have much lower risk of overdose death, infectious disease, and criminal involvement, higher retention in treatment, and better employment and relationships than those who do not. Dependence on a medication taken under medical supervision, in a stable dose, is different from addiction, which involves compulsive use despite harm. Stopping such medication too early is associated with high relapse rates, so the decision about duration should be made with a clinician.
Do I have to hit rock bottom before I can recover?
No. This belief is a myth that can delay help and cost lives. Research shows that earlier intervention generally leads to better outcomes, with less harm accumulated, and that people who enter treatment under pressure from family, employers, or courts can do as well as those who enter voluntarily. Motivation for change is not fixed and can be built through approaches such as motivational interviewing. There is no need to wait for a catastrophe, and anyone who recognizes that substance use is causing problems can seek help at any stage.
How can I help someone who keeps relapsing?
Stay calm, avoid blame, and remind the person of their strengths and previous progress. Express concern, encourage a quick return to treatment and support, and help with practical steps such as making appointments. Avoid enabling, such as covering up the consequences or giving money that may be used for substances, but avoid cutting off contact unless safety requires it. If opioids are involved, keep naloxone available and learn how to use it. Programs such as community reinforcement and family training teach effective communication and increase the chance that a reluctant person will engage with treatment. Look after your own health and consider support groups such as Al-Anon or Nar-Anon, since the strain on families is considerable.
What is urge surfing?
Urge surfing is a mindfulness technique developed by Alan Marlatt for managing cravings. Instead of fighting the urge or giving in, the person observes it with curiosity, noticing where it is felt in the body, how intense it is, and how it changes, imagining it as an ocean wave that rises, reaches a peak, and falls away. The practice is based on the observation that urges are temporary and that resisting them tends to make them stronger. It helps to interrupt the automatic link between trigger and use and builds confidence that cravings can be tolerated. Studies of mindfulness-based relapse prevention, which includes this technique, show reductions in relapse and heavy use.
Can the brain recover after long-term substance use?
Substantially, in many cases, although the time course and extent of recovery vary with the substance, the duration and intensity of use, age, and individual factors. Brain imaging studies show partial recovery of dopamine function and prefrontal activity over months to years of abstinence, with improvements in cognition, mood, and decision making. For example, a study of former methamphetamine users found significant recovery of dopamine transporters after about fourteen months of abstinence. Some changes recover more slowly or incompletely, and the early months can be a period of low mood and impaired concentration. Exercise, sleep, good nutrition, treatment of other conditions, and continuing support all promote recovery, and the brain’s plasticity offers grounds for hope.
Recommended Books on Addiction, Craving, and Recovery
- Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors by G. Alan Marlatt and Dennis M. Donovan
- Motivational Interviewing: Helping People Change and Grow by William R. Miller and Stephen Rollnick
- Mindfulness-Based Relapse Prevention for Addictive Behaviors: A Clinician’s Guide by Sarah Bowen, Neha Chawla, and G. Alan Marlatt
- Dopamine Nation: Finding Balance in the Age of Indulgence by Anna Lembke
- Unbroken Brain: A Revolutionary New Way of Understanding Addiction by Maia Szalavitz
- In the Realm of Hungry Ghosts: Close Encounters with Addiction by Gabor Maté
- Beyond Addiction: How Science and Kindness Help People Change by Jeffrey Foote, Carrie Wilkens, and Nicole Kosanke
- Never Enough: The Neuroscience and Experience of Addiction by Judith Grisel
- Clean: Overcoming Addiction and Ending America’s Greatest Tragedy by David Sheff
- Recovery: Freedom from Our Addictions by Russell Brand
